Venkys (India) Ltd
Venky’s India Ltd, a part of the VH group, is majorly engaged in poultry breeding and chicken meat processing. [1]
- Market Cap ₹ 2,281 Cr.
- Current Price ₹ 1,619
- High / Low ₹ 2,560 / 1,522
- Stock P/E 19.6
- Book Value ₹ 1,047
- Dividend Yield 0.43 %
- ROCE 11.2 %
- ROE 8.20 %
- Face Value ₹ 10.0
Pros
Cons
- The company has delivered a poor sales growth of 0.28% over past five years.
- Company has a low return on equity of 6.61% over last 3 years.
- Dividend payout has been low at 12.2% of profits over last 3 years
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: FMCG Industry: Miscellaneous
Part of BSE Fast Moving Consumer Goods BSE SmallCap BSE Allcap
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
1,736 | 1,731 | 2,127 | 2,476 | 2,686 | 3,043 | 3,261 | 3,117 | 4,400 | 4,234 | 3,738 | 3,307 | |
1,669 | 1,631 | 1,990 | 2,198 | 2,299 | 2,734 | 3,282 | 2,728 | 4,154 | 4,122 | 3,615 | 3,135 | |
Operating Profit | 67 | 100 | 137 | 278 | 388 | 309 | -21 | 389 | 246 | 112 | 123 | 172 |
OPM % | 4% | 6% | 6% | 11% | 14% | 10% | -1% | 12% | 6% | 3% | 3% | 5% |
40 | 34 | 32 | 34 | 27 | 28 | 35 | 36 | 34 | 37 | 39 | 44 | |
Interest | 43 | 74 | 85 | 77 | 50 | 32 | 30 | 28 | 18 | 18 | 18 | 16 |
Depreciation | 19 | 32 | 30 | 28 | 28 | 29 | 34 | 35 | 37 | 35 | 35 | 37 |
Profit before tax | 45 | 28 | 54 | 206 | 337 | 277 | -50 | 361 | 226 | 95 | 109 | 163 |
Tax % | 25% | 33% | 29% | 39% | 41% | 37% | -45% | 26% | 27% | 26% | 28% | 28% |
34 | 19 | 38 | 125 | 200 | 174 | -27 | 268 | 165 | 70 | 79 | 117 | |
EPS in Rs | 24.14 | 13.26 | 27.14 | 88.55 | 141.77 | 123.61 | -19.28 | 190.06 | 116.97 | 50.03 | 56.13 | 82.78 |
Dividend Payout % | 14% | 25% | 18% | 7% | 6% | 6% | 0% | 9% | 11% | 12% | 12% | 12% |
Compounded Sales Growth | |
---|---|
10 Years: | 7% |
5 Years: | 0% |
3 Years: | -9% |
TTM: | -12% |
Compounded Profit Growth | |
---|---|
10 Years: | 22% |
5 Years: | 44% |
3 Years: | -11% |
TTM: | 47% |
Stock Price CAGR | |
---|---|
10 Years: | 24% |
5 Years: | 10% |
3 Years: | -6% |
1 Year: | -11% |
Return on Equity | |
---|---|
10 Years: | 13% |
5 Years: | 11% |
3 Years: | 7% |
Last Year: | 8% |
Balance Sheet
Figures in Rs. Crores
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 9 | 9 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 | 14 |
Reserves | 358 | 362 | 405 | 517 | 707 | 867 | 822 | 1,090 | 1,235 | 1,285 | 1,356 | 1,461 |
626 | 762 | 746 | 545 | 350 | 268 | 310 | 186 | 199 | 191 | 172 | 170 | |
231 | 287 | 340 | 285 | 360 | 408 | 451 | 499 | 499 | 526 | 552 | 425 | |
Total Liabilities | 1,224 | 1,420 | 1,504 | 1,360 | 1,431 | 1,557 | 1,597 | 1,790 | 1,947 | 2,015 | 2,094 | 2,070 |
435 | 476 | 473 | 468 | 472 | 501 | 571 | 618 | 603 | 592 | 618 | 645 | |
CWIP | 34 | 9 | 7 | 8 | 17 | 66 | 53 | 10 | 14 | 34 | 28 | 8 |
Investments | 52 | 62 | 2 | 2 | 0 | 6 | 7 | 45 | 70 | 90 | 105 | 122 |
703 | 874 | 1,022 | 882 | 942 | 984 | 966 | 1,116 | 1,260 | 1,299 | 1,343 | 1,296 | |
Total Assets | 1,224 | 1,420 | 1,504 | 1,360 | 1,431 | 1,557 | 1,597 | 1,790 | 1,947 | 2,015 | 2,094 | 2,070 |
Cash Flows
Figures in Rs. Crores
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
-56 | 59 | 78 | 211 | 256 | 159 | 58 | 242 | 5 | 86 | 82 | 66 | |
-221 | -113 | 51 | 57 | -29 | -38 | -53 | -46 | -19 | -27 | -37 | -38 | |
252 | 52 | -112 | -280 | -245 | -120 | -9 | -148 | -34 | -45 | -47 | -30 | |
Net Cash Flow | -24 | -1 | 18 | -12 | -18 | 0 | -4 | 48 | -48 | 15 | -2 | -2 |
Ratios
Figures in Rs. Crores
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 35 | 48 | 53 | 39 | 40 | 37 | 50 | 46 | 53 | 57 | 70 | 61 |
Inventory Days | 53 | 60 | 23 | 23 | 32 | 35 | 15 | 36 | 19 | 21 | 21 | 37 |
Days Payable | 38 | 51 | 56 | 36 | 45 | 47 | 52 | 57 | 41 | 46 | 53 | 44 |
Cash Conversion Cycle | 50 | 58 | 20 | 27 | 27 | 25 | 13 | 24 | 31 | 31 | 38 | 55 |
Working Capital Days | 44 | 47 | 50 | 33 | 30 | 40 | 27 | 45 | 50 | 51 | 60 | 87 |
ROCE % | 9% | 9% | 12% | 25% | 36% | 28% | -2% | 32% | 18% | 8% | 8% | 11% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
17 May - Venky''s (India) Limited Earnings Call 13th May 2025 Transcript.
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
13 May - Link provided for Venky's FY2025 earnings call audio recording.
-
Announcement under Regulation 30 (LODR)-Press Release / Media Release
12 May - Q4 FY25 results: Rs.843 Cr revenue, Rs.13.3 Cr PAT; Rs.70 Cr SPF eggs expansion; Rs.16 Cr spices launch.
-
Capacity Expansion And New Product Launch
12 May - Rs.70Cr SPF eggs expansion and Rs.16Cr ready-to-cook spices launch by FY 2026-27.
-
Announcement under Regulation 30 (LODR)-Dividend Updates
12 May - Board recommends Rs.10 per share final dividend for FY 2024-25, subject to AGM approval.
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from nse
Concalls
-
May 2025TranscriptPPT
-
Feb 2025TranscriptNotesPPT
-
Nov 2024Transcript PPT
-
May 2024Transcript PPT
-
Feb 2024TranscriptNotesPPT
-
Nov 2023Transcript PPT
-
May 2023TranscriptPPT
-
May 2022TranscriptPPT
-
Nov 2021TranscriptPPT
-
May 2021TranscriptPPT
-
Feb 2021Transcript PPT
Business Segments[1]
Poultry & poultry products: This segment is engaged in the production and sale of day-old broiler & layer chicks, the production of specific pathogen-free (SPF) eggs, etc.
Animal Health products: This segment is engaged in the manufacturing of medicines and poultry feed supplements.
Oilseed segment: This segment is engaged in the processing of soya.